Alt M, Müller R, Kontermann R E
Institut für Molekularbiologie und Tumorforschung, Philipps-Universität Marburg, Germany.
FEBS Lett. 1999 Jul 2;454(1-2):90-4. doi: 10.1016/s0014-5793(99)00782-6.
Although bispecific IgG molecules have been successfully applied for antibody-mediated immunotherapy of tumours, applicability is hampered by the difficulties associated with their generation. In the present study, we have used a bispecific single-chain diabody (scDb) directed against carcinoembryonic antigen and Escherichia coli beta-galactosidase as a model to generate bispecific IgG-like antibody molecules. We show that the fusion of this single-chain diabody to the Fc (scDb-Fc) or CH3 (scDb-CH3) region of the human immunoglobulin gamma1 chain results in the expression of dimeric fusion proteins exhibiting four functional antigen binding sites with increased functional affinity. This strategy represents a new and convenient way to generate IgG-like multivalent and bispecific molecules that are efficiently secreted from mammalian cells.
尽管双特异性IgG分子已成功应用于肿瘤的抗体介导免疫治疗,但其生成过程中存在的困难限制了其适用性。在本研究中,我们使用了一种针对癌胚抗原和大肠杆菌β-半乳糖苷酶的双特异性单链双抗体(scDb)作为模型,来生成双特异性IgG样抗体分子。我们发现,将这种单链双抗体与人免疫球蛋白γ1链的Fc(scDb-Fc)或CH3(scDb-CH3)区域融合,会导致二聚体融合蛋白的表达,该融合蛋白具有四个功能性抗原结合位点,且功能亲和力增加。这一策略代表了一种生成IgG样多价和双特异性分子的新的便捷方法,这些分子能够从哺乳动物细胞中有效分泌。